Preoperative nivolumab to evaluate pathological response in patients with stage I non-small cell lung cancer: a study protocol of phase II trial (POTENTIAL).

Atsushi Kagimoto Yasuhiro TsutaniTakahiro MimaeYoshihiro MiyataNorihiko IkedaHiroyuki ItoYoshimasa ManiwaKenji SuzukiMasahiro TsuboiKenichi YoshimuraSeiji UmemotoMorihito Okada

Published in: BMJ open (2021)

jRCT2061180016.

Keyphrases

study protocol
open label
randomized controlled trial
patients undergoing
placebo controlled
human health
double blind
risk assessment